PMID: 30 JinT
Phillip M, Mathieu C, Lind M et al (2021) Long-term efficacy and safety of dapagliflozin in patients with inadequately controlled type 1 diabetes: pooled 52-week outcomes from the DEPICT-1 and -2 studies
Fighting extreme hunger with severe restriction will backfire, leading to binge episodes and potentially larger weight regain than a moderate approach
Today, there are GLP-1 drugs made for diabetic patients (e.g., Ozempic and Mounjaro) and GLP-1s intended for weight loss patients (e.g., Wegovy and Zepbound)
Keep reading Published on: November 22, 2024 Support Childrens Health During iHeartMedia Cares for Kids Radiothon This holiday season, you can support Wellstar Childrens Hospital of Georgia, a Childrens Miracle Network hospital, by tuning in to the 24th Annual iHeartMedia Cares for Kids Radiothon
Always report suspected side effects to your healthcare professional and consider using the MHRA Yellow Card scheme to report adverse reactions